Analysis of Guided Therapeutics’ FDA Study Data Reveals Compelling Clinical Need for LuViva
PEACHTREE CORNERS, Ga.–(BUSINESS WIRE)–Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless…
Pharmaceuticals, Biotechnology and Life Sciences
PEACHTREE CORNERS, Ga.–(BUSINESS WIRE)–Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless…
SEOUL, South Korea–(BUSINESS WIRE)–#AI—Galux, a South Korean biotech pioneering AI-driven protein therapeutics discovery, announced that it has signed a research…
First-of-its-kind hospitality partnership brings biotech-backed ‘social wellness’ to one of the world’s premier après destination resorts SAN FRANCISCO–(BUSINESS WIRE)–ZBiotics®, the…
Study did not demonstrate statistically significant improvement on primary endpoint of reduction in anxiety as measured by SUDS scores compared…
Company recognized for advancing ENV‑105, a first‑in‑class resistance‑modulating antibody for metastatic castration‑resistant prostate cancer LOS ANGELES–(BUSINESS WIRE)–Kairos Pharma Ltd. (NYSE…
CAMBRIDGE, Mass. & LONDON–(BUSINESS WIRE)–Valink Therapeutics (“Valink”), a private biotechnology company developing next-generation therapeutics with a focus on bispecific antibody-drug…
SAN DIEGO–(BUSINESS WIRE)–Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced…
ENV-308 is a first-in-class, once-daily oral therapy designed for chronic weight management, emphasizing high-quality weight loss with muscle mass preservation…
— Submission supported by positive preliminary 18-month NAUTILUS data in patients with drug-resistant idiopathic generalized epilepsy (IGE) and generalized tonic-clonic…
SCHAUMBURG, Ill.–(BUSINESS WIRE)–Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced that it will be attending…